Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RAC1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RAC1 is a Rho GTPase regulating actin cytoskeleton, synaptic plasticity, mitochondrial dynamics, and neuroinflammation in neurodegenerative diseases including Alzheimer's and Parkinson's
No AI portrait yet
| Gene Symbol | RAC1 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 21.4 kDa |
| Amino Acids | 192 aa |
| Pathways | Apoptosis, Autophagy, Dendritic Spine, Mtor, Nf-Κb |
| Ensembl ID | ENSG00000136238 |
| GeneCards | RAC1 |
| Human Protein Atlas | RAC1 |
| Associated Diseases | Als, Cancer, Diabetes, Encephalitis, Inflammation |
| Interactions | ACTB, Actin, ACVR1, AKT, AKT1, ALZHEIMER |
| KG Connections | 487 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
RAC1["RAC1
Small GTPase"]
HACE1["HACE1
E3 Ubiquitin Ligase"]
YAP["YAP
Transcriptional
Coactivator"]
PIK3C3["PIK3C3
Autophagy Regulator"]
ATG14["ATG14
Autophagy Gene"]
GJA1["GJA1
Gap Junction
Protein"]
LAMP1["LAMP1
Lysosomal Protein"]
ALS["Amyotrophic
Lateral Sclerosis"]
MS["Multiple
Sclerosis"]
PD["Parkinson's
Disease"]
Stroke["Stroke"]
TBI["Traumatic
Brain Injury"]
Inflammation["Neuroinflammation"]
Autophagy["Autophagy
Dysfunction"]
CellMigration["Cell Migration
and Motility"]
Neuroprotection["Neuroprotective
Response"]
HACE1 -->|"regulates"| RAC1
RAC1 -->|"activates"| YAP
RAC1 -->|"regulates"| PIK3C3
RAC1 -->|"regulates"| ATG14
RAC1 -->|"regulates"| GJA1
RAC1 -->|"associates_with"| LAMP1
PIK3C3 -->|"promotes"| Autophagy
ATG14 -->|"promotes"| Autophagy
LAMP1 -->|"facilitates"| Autophagy
RAC1 -->|"promotes"| CellMigration
YAP -->|"enhances"| CellMigration
RAC1 -->|"inhibits"| TBI
RAC1 -->|"promotes"| Neuroprotection
RAC1 -->|"therapeutic_target"| ALS
RAC1 -->|"therapeutic_target"| MS
RAC1 -->|"therapeutic_target"| PD
RAC1 -->|"therapeutic_target"| Inflammation
RAC1 -->|"activates"| ALS
RAC1 -->|"activates"| Stroke
Autophagy -->|"contributes_to"| ALS
Inflammation -->|"worsens"| MS
style RAC1 fill:#006494
style HACE1 fill:#4a1a6b
style PIK3C3 fill:#4a1a6b
style ATG14 fill:#4a1a6b
style Neuroprotection fill:#1b5e20
style TBI fill:#ef5350
style ALS fill:#ef5350
style MS fill:#ef5350
style Stroke fill:#ef5350
style Inflammation fill:#ef5350
style Autophagy fill:#5d4400
style CellMigration fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Synapse Formation | regulates | process | 0.88 |
| Synaptogenesis | involved_in | process | 0.85 |
| Type 2 Diabetes Mellitus with Parkinson's Disease | biomarker_for | disease | 0.80 |
| Synoviocyte Hyperplasia | promotes | phenotype | 0.80 |
| Oxidative Stress | associated_with | process | 0.80 |
| Alzheimer | contributes_to | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Huntington | contributes_to | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Obesity | therapeutic_target | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Aging | interacts_with | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Lymphoma | interacts_with | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Cancer | causes | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Parkinson | interacts_with | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Traumatic Brain Injury | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ARHGEF7 | activates | protein | 0.90 |
| VAV2 | phosphorylates | protein | 0.85 |
| SAA | binds | protein | 0.80 |
| ARHGEF2 | activates | gene | 0.80 |
| PLEKHG5 | activates | gene | 0.80 |
| HACE1 | interacts_with | protein | 0.70 |
| TPM2 | associated_with | gene | 0.70 |
| NRAS | activates | gene | 0.60 |
| SCIN | associated_with | gene | 0.60 |
| CKLF1 | activates | gene | 0.60 |
| YAP | activates | gene | 0.60 |
| RHOC | activates | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| PARKINSON'S DISEASE | interacts_with | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| ERK | associated_with | gene | 0.60 |
| AUTOPHAGY | regulates | gene | 0.60 |
| SYNAPSE | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| P21 | activates | gene | 0.60 |
| GLIOBLASTOMA | activates | gene | 0.60 |
| STROKE | activates | gene | 0.60 |
| RAS | activates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| RAS | regulates | gene | 0.60 |
| NF-ΚB | regulates | gene | 0.60 |
| MYELIN | activates | gene | 0.60 |
| ASTROCYTE | activates | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| IL6 | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| TFEB | activates | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| ATG16L1 | activates | gene | 0.60 |
| ELP3 | activates | gene | 0.60 |
| GBM | activates | gene | 0.60 |
| RBFOX2 | expressed_in | gene | 0.60 |
| PAK1 | regulates | gene | 0.60 |
| RYR2 | activates | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| PIK3CA | interacts_with | gene | 0.60 |
| RANKINGS | interacts_with | gene | 0.60 |
| SOD2 | associated_with | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| PTGS2 | activates | gene | 0.60 |
| BRAF | activates | gene | 0.60 |
| NF1 | activates | gene | 0.60 |
| LRRK2 | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning RAC1 in their description or question text
No additional research found